Intriguingly, obesity is associated with elevated corticosterone, and treatment with the potent glucocorticoid receptor (GR) antagonist RU486 can combat obesity and related complications (29, 34, 48, 67). The gene discussed is NR3C1; the disease is obesity due to melanocortin 4 receptor deficiency.